CYTARABINE ACCORD 20 mg/ml, solution for injection/for infusion bottle, 5 ml
Active ingredients: Cytarabine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusionbottle, 5 mlintramusculaire;intrathécale;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CYTARABINE ACCORD 20 mg/mL, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intrathécale;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon en verre de 5 ml
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Sept 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63625385CIP75505799CIP133400955057994Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYTARABINEsolution | 20 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.